These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1794156)

  • 1. Effect of basal gastric acid secretion on the pharmacodynamics of ranitidine.
    Sanders SW; Ballersteros MA; Hogan DL; Koss MA; Isenberg JI
    Chronobiol Int; 1991; 8(3):186-93. PubMed ID: 1794156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
    Sanders SW; Bishop AL; Moore JG
    Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day-night and individual differences in response to constant-rate ranitidine infusion.
    White C; Smolensky MH; Sanders SW; Buchi KN; Moore JG
    Chronobiol Int; 1991 Feb; 8(1):56-66. PubMed ID: 1814603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers.
    Sanders SW; Buchi KN; Moore JG; Bishop AL
    Clin Pharmacol Ther; 1989 Nov; 46(5):545-51. PubMed ID: 2582711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.
    Kummer AF; Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger SA
    Gut; 1992 Feb; 33(2):175-8. PubMed ID: 1541412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in basal nocturnal, meal-stimulated, and pentagastrin-stimulated gastric secretion values in a sample of healthy volunteers in basal conditions and under ranitidine influence.
    Carranza-Madrigal J; Herrera-Abaraca JE; Chavez-Carbajal F; Campos-Perez Y; Salazar LA
    Control Clin Trials; 1996 Jun; 17(3):258-65. PubMed ID: 8877261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-secretory effects and pharmacokinetics of low dose ranitidine.
    Koss MA; Hogan DL; Lane J; Steinbach JH; Isenberg JI
    Aliment Pharmacol Ther; 1993 Aug; 7(4):417-22. PubMed ID: 8218756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of gastric pH with ranitidine in critically ill patients. Comparison of two intravenous regimens.
    Santucci L; Fiorucci S; Pelli MA; Calderazzo A; Biasini E; Calderazzo PL; Morelli A
    Dig Dis Sci; 1991 May; 36(5):583-7. PubMed ID: 2022159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of fasting on 24-h gastric secretion of patients with duodenal ulcers resistant to ranitidine.
    Johnston DA; Wormsley KG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):471-9. PubMed ID: 2518860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy.
    Prichard PJ; Jones DB; Yeomans ND; Mihaly GW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1986 Dec; 22(6):663-8. PubMed ID: 3567013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
    Lewis JH
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():15-24. PubMed ID: 1888834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J
    Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.
    Jones DB; Howden CW; Burget DW; Silletti C; Hunt RH
    Gut; 1988 Jul; 29(7):890-3. PubMed ID: 2969357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 800 mg cimetidine once daily on gastric acid secretion.
    Dammann HG; Walter TA; Mueller P; Simon B
    Scand J Gastroenterol Suppl; 1986; 121():25-9. PubMed ID: 3532295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time of administration influences gastric inhibitory effects of ranitidine.
    Johnston DA; Wormsley KG
    Scand J Gastroenterol; 1988 Nov; 23(9):1137-40. PubMed ID: 3247592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
    Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
    Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.